MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGEN EXPRESSION IN THE AFFECTED TISSUES IN AMYOTROPHIC-LATERAL-SCLEROSIS

被引:89
|
作者
LAMPSON, LA
KUSHNER, PD
SOBEL, RA
机构
[1] PACIFIC PRESBYTERIAN MED CTR, ALS & NEUROMUSCULAR RES FDN, SAN FRANCISCO, CA USA
[2] MASSACHUSETTS GEN HOSP, DEPT PATHOL, BOSTON, MA 02114 USA
[3] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA
关键词
D O I
10.1002/ana.410280311
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Monoclonal antibody immunocytochemsitry was used to examine spinal cord and muscle in amyotrophic lateral sclerosis for changes that would indicate ongoing or potential immune activity. Increased expression of class I and II major histocompatibility complex (MHC) antigens was seen in the affected areas of spinal cord. New MHC expression was concentrated in phagocytes, particularly in degenerating white matter in which they were dispersed in the tissue and also packed around blood vessels. MHC antigen was not revealed in motor neurons or skeletal muscle fibers. An anti‐pan–T‐cell monoclonal revealed small numbers of T cells in degenerating white matter. Similar changes have been seen in other neurodegenerative disorders. They suggest a potential for (secondary) cell‐mediated activity in the affected areas rather than an ongoing MHC‐restricted T‐Cell response. Vessel‐associated phagocytes may be a source of antigen to peripheral lymphoid tissue, stimulating production of the autoantibodies that have been described. Copyright © 1990 American Neurological Association
引用
收藏
页码:365 / 372
页数:8
相关论文
共 50 条
  • [21] EXPRESSION OF UNIQUE GENES IN SUBTRACTED AMYOTROPHIC-LATERAL-SCLEROSIS LIBRARIES
    RICKERT, K
    KELLEYGERAGHTY, DC
    JUBELT, B
    ANNALS OF NEUROLOGY, 1995, 38 (02) : 293 - 293
  • [22] ANTIGENIC POLYMORPHISM IN AMYOTROPHIC-LATERAL-SCLEROSIS
    DRAKINA, SA
    VOTYAKOV, VI
    PROTAS, II
    SEMENOV, GV
    LEVIN, VI
    PRYALKINA, SM
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 1987, 87 (02): : 209 - 211
  • [23] AMYOTROPHIC-LATERAL-SCLEROSIS PRESENTING WITH PSYCHOSIS
    ENNS, MW
    BARAKAT, SM
    BROWN, JH
    PSYCHOSOMATICS, 1993, 34 (05) : 453 - 455
  • [24] NEUROPSYCHOLOGICAL PERSPECTIVES IN AMYOTROPHIC-LATERAL-SCLEROSIS
    MONTGOMERY, GK
    ERICKSON, LM
    NEUROLOGIC CLINICS, 1987, 5 (01) : 61 - 81
  • [25] AMYOTROPHIC-LATERAL-SCLEROSIS WITH ANTECEDENT POLIOMYELITIS
    OMARDEEN, FL
    MORGAN, OS
    WEST INDIAN MEDICAL JOURNAL, 1992, 41 (02): : 84 - 85
  • [26] MISDIAGNOSIS IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS
    BELSH, JM
    SCHIFFMAN, PL
    ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (11) : 2301 - 2305
  • [27] MOLECULAR APPROACHES TO AMYOTROPHIC-LATERAL-SCLEROSIS
    SMITH, RG
    APPEL, SH
    ANNUAL REVIEW OF MEDICINE, 1995, 46 : 133 - 145
  • [28] AMYOTROPHIC-LATERAL-SCLEROSIS - A MULTIFACTORIAL DISEASE
    EISEN, AA
    PATHOGENESIS AND THERAPY OF AMYOTROPHIC LATERAL SCLEROSIS, 1995, 68 : 121 - 134
  • [29] AMYOTROPHIC-LATERAL-SCLEROSIS - IS EXCITOTOXICITY THE KEY
    KRUEGER, G
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1994, 151 (04) : 441 - 443
  • [30] VASCULAR AUTOANTIBODIES IN AMYOTROPHIC-LATERAL-SCLEROSIS
    GREINER, A
    MARX, A
    MULLERHERMELINK, HK
    SCHMAUSSER, B
    PETZOLD, K
    KRUGER, H
    LANCET, 1992, 340 (8815): : 378 - 379